Sarah Thomas is the Vice President of Quality at REGENXBIO, responsible for the Quality Assurance, Quality Control and Analytical Development organizations. She has over 30 years’ experience in pharmaceutical, biotech & gene therapy Quality. She has experience working with products at all phases of development, from early clinical phases to commercial distribution. She has led Quality teams through the transition from clinical to commercial operations, and through multiple product approvals. Ms. Thomas received an MBA from George Washington University and a BS in chemistry from Butler University.